ANDA 72574, held by Mylan. Prazosin Hydrochloride.
As of Nov 16, 2026, ANDA 72574 (Prazosin Hydrochloride), held by Mylan, was first approved by FDA on Feb 28, 1989, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 28, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prazosin HydrochlorideEQ 2MG BASE ยท capsule; oral | Prazosin Hydrochloride | Rx |
| Jun 3, 2002 | Supplement 8Labeling | Approved | None posted |
| Aug 1, 2000 | Supplement 7Manufacturing | Approved | None posted |
| Feb 25, 1998 | Supplement 6Manufacturing | Approved | None posted |
| Feb 5, 1998 | Supplement 5Manufacturing | Approved | None posted |
| Oct 15, 1993 | Supplement 4Manufacturing | Approved | None posted |
| Oct 4, 1990 | Supplement 2Labeling | Approved | None posted |
| Jan 31, 1990 | Supplement 1Manufacturing | Approved | None posted |
| Feb 28, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters